Familial thyroid carcinoma: the road less travelled in thyroid pathology

Diagnostic Histopathology

Volumn 15, Issue 2, 2009, Pages 87-94

  LiVolsi, Virginia A ^a   Baloch, Zubair W ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

C cell tumors; familial tumors; syndromic neoplasms; thyroid cancer

Indexed keywords

ADENOMATOUS POLYP; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FAMILIAL CANCER; HISTOPATHOLOGY; HUMAN; NEUROFIBROMATOSIS; ONCOCYTOMA; PROGNOSIS; SIPPLE SYNDROME; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA;

EID: 61649117893     PISSN: 17562317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2009.01.002     Document Type: Article

References (50)

1. Nikiforov Y., Gnepp D.R., and Fagin J.A. Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis. J Clin Endocrinol Metab 81 (1996) 9-14
2. Nikiforov Y.E. RET/PTC rearrangement in thyroid tumors. Endocr Pathol 13 (2002) 3-16
3. Elisei R., Ugolini C., Viola D., et al. BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab 93 (2008) 3943-3949
4. Eng C. Familial papillary thyroid cancer - many syndromes, too many genes?. J Clin Endocrinol Metab 85 (2000) 1755-1757
5. Dotto J., and Nose V. Familial thyroid carcinoma: a diagnostic algorithm. Adv Anat Pathol 15 (2008) 332-349
6. Leboulleux S., Baudin E., Travagli J.P., and Schlumberger M. Medullary thyroid carcinoma. Clin Endocrinol (Oxf) 61 (2004) 299-310
7. Horn R.C. Carcinoma of the thyroid: description of a distinctive morphologic variant and report of seven cases. Cancer 4 (1951) 697-707
8. Hazard J.B., Hawk W.A., and Crile G. Medullary (solid) carcinoma of the thyroid. A clinicopathologic entity. J Clin Endocrinol Metab 19 (1959) 152-161
9. Copp D.H. Calcitonin and parathyroid hormone. Annu Rev Pharmacol 9 (1969) 327-344
10. Sipple J.H. The association of pheochromocytoma with carcinoma of the thyroid gland. Am J Med 31 (1961) 163-166
11. Williams E.D. Histogenesis of medullary carcinoma of the thyroid. J Clin Pathol 19 (1966) 114-118
12. Mulligan L.M., Eng C., Attie T., et al. Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum Mol Genet 3 (1994) 2163-2167
13. Massoll N., and Mazzaferri E.L. Diagnosis and management of medullary thyroid carcinoma. Clin Lab Med 24 (2004) 49-83
14. Asa S.L. How familial cancer genes and environmentally induced oncogenes have changed the endocrine landscape. Mod Pathol 14 (2001) 246-253
15. Eng C. RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschprung's disease. Semin Med Beth Israel Hosp Boston 335 (1996) 943-951
16. Kebebew E., Ituarte P.H., Siperstein A.E., Duh Q.Y., and Clark O.H. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88 (2000) 1139-1148
17. Eng C. RET proto-oncogene in the development of human cancer. J Clin Oncol 17 (1999) 380-393
18. Sheikh H.A., Tometsko M., Niehouse L., et al. Molecular genotyping of medullary thyroid carcinoma can predict tumor recurrence. Am J Surg Pathol 28 (2004) 101-106
19. Jimenez C., Habra M.A., Huang S.C., et al. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation. J Clin Endocrinol Metab 89 (2004) 4142-4145
20. Albores-Saavedra J., LiVolsi V.A., and Williams E.D. Medullary carcinoma. Semin Diagn Pathol 2 (1985) 137-146
21. Evans D.B., Burgess M.A., Goepfert H., and Gagel R.F. Medullary thyroid carcinoma. Curr Ther Endocrinol Metab 6 (1997) 127-132
22. de Lellis R.A., and Wolfe H.J. The pathobiology of the human calcitonin (C)-cell: a review. Pathol Annu 16 (1981) 25-52
23. Etit D., Faquin W.C., Gaz R., Randolph G., DeLellis R.A., and Pilch B.Z. Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: a study of 42 cases. Arch Pathol Lab Med 132 (2008) 1767-1773
24. DeLellis R., Nunnemacher G., and Wolfe H. C-cell hyperplasia: an ultrastructural analysis. Lab Invest 36 (1978) 237-248
25. Albores-Saavedra J., Monforte H., Nadji M., and Morales A.R. C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors. Hum Pathol 19 (1988) 795
26. Gibson W., Peng T., and Croker B. C-cell nodules in adult human thyroid: a common autopsy finding. Am J Clin Pathol 73 (1980) 347-351
27. Komminoth P., Roth J., Saremasiani P., et al. Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions. Am J Surg Pathol 18 (1994) 399
28. Wolfe H.J., Melvin K.E., Cervi-Skinner S.J., et al. C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med 289 (1973) 437-441
29. Albores-Saavedra J.A., and Krueger J.E. C-cell hyperplasia and medullary thyroid microcarcinoma. Endocr Pathol 12 (2001) 365-377
30. Guyetant S., Dupre F., Bigorgne J.C., et al. Medullary thyroid microcarcinoma: a clinicopathologic retrospective study of 38 patients with no prior familial disease. Hum Pathol 30 (1999) 957-963
31. Weinhaeusel A., Scheuba C., Lauss M., et al. The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma. Thyroid 18 (2008) 1269-1276
32. Nose V. Familial non-medullary thyroid carcinoma: an update. Endocr Pathol (2008 Oct 18) Epub ahead of print
33. Malchoff C.D., and Malchoff D.M. Familial nonmedullary thyroid carcinoma. Cancer Control 13 (2006) 106-110
34. Brunaud L., Zarnegar R., Wada N., et al. Chromosomal aberrations by comparative genomic hybridization in thyroid tumors in patients with familial nonmedullary thyroid cancer. Thyroid 13 (2003) 621-629
35. Bevan S., Pal T., Greenberg C.R., et al. A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1. J Clin Endocrinol Metab 86 (2001) 3701-3704
36. Goto M., Miller R.W., Ishikawa Y., and Sugano H. Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev 5 (1996) 239-246
37. Blumenthal G.M., and Dennis P.A. PTEN hamartoma tumor syndromes. Eur J Hum Genet 16 (2008) 1289-1300
38. Stratakis C.A. Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes. J Endocrinol Invest 24 (2001) 370-383
39. Stratakis C.A., Kirschner L.S., Taymans S.E., et al. Carney complex, Peutz-Jeghers syndrome, Cowden disease, and Bannayan-Zonana syndrome share cutaneous and endocrine manifestations, but not genetic loci. J Clin Endocrinol Metab 83 (1998) 2972-2976
40. Marsh D.J., Coulon V., Lunetta K.L., et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 7 (1998) 507-515
41. Kraimps J.L., Bouin-Pineau M.H., Amati P., et al. Familial papillary carcinoma of the thyroid. Surgery 121 (1997) 715-718
42. Cavaco B.M., Batista P.F., Martins C., et al. Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations. Endocr Relat Cancer 15 (2008) 207-215
43. Bakhsh A., Kirov G., Gregory J.W., Williams E.D., and Ludgate M. A new form of familial multi-nodular goitre with progression to differentiated thyroid cancer. Endocr Relat Cancer 13 (2006) 475-483
44. Cavaco B.M., Batista P.F., Sobrinho L.G., and Leite V. Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis. J Clin Endocrinol Metab 93 (2008) 4426-4430
45. Fenton P.A., Clarke S.E., Owen W., Hibbert J., and Hodgson S.V. Cribriform variant papillary thyroid cancer: a characteristic of familial adenomatous polyposis. Thyroid 11 (2001) 193-197
46. Lupoli G., Vitale G., Caraglia M., et al. Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 353 (1999) 637-639
47. Ng S.B., Sittampalam K., Goh Y.H., and Eu K.W. Cribriform-morular variant of papillary carcinoma: the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma. A case report with clinical and molecular genetic correlation. Pathology 35 (2003) 42-46
48. Sippel R.S., Caron N.R., and Clark O.H. An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World J Surg 31 (2007) 924-933
49. Chan J.K., and Loo K.T. Cribriform variant of papillary thyroid carcinoma. Arch Pathol Lab Med 114 (1990) 622-624
50. Subramaniam M.M., Putti T.C., Anuar D., et al. Clonal characterization of sporadic cribriform-morular variant of papillary thyroid carcinoma by laser microdissection-based APC mutation analysis. Am J Clin Pathol 128 (2007) 994-1001